✦ LIBER ✦

TP53 in hematological cancer: Low incidence of mutations with significant clinical relevance

✍ Scribed by Shoshana Peller; Varda Rotter

Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 127 KB
Volume: 21
Category: Article
ISSN: 1059-7794
DOI: 10.1002/humu.10190

No coin nor oath required. For personal study only.

✦ Synopsis

Inactivation of the wild-type p53 gene (TP53) by various genetic alterations is a major event in human tumorigenesis. More than 60% of human primary tumors exhibit a mutation in the p53 gene. Hematological malignancies present a rather low incidence of genetic alterations in this gene (10-20%). Nevertheless, epidemiological studies of the hematological malignancies indicate that the prognosis of patients with a mutation in the p53 gene is worse than those expressing the wild-type p53 protein. Correlations between drug resistance, altered apoptosis, and mutations in the p53 gene are found in hematological malignancies and leukemias. These issues, as well as the possibility of exploiting p53 and its various functions for new therapeutic strategies, are discussed in the present review.

📜 SIMILAR VOLUMES

Significance of TP53 mutations in human

Significance of TP53 mutations in human cancer: A critical analysis of mutations at CpG dinucleotides

✍ Thierry Soussi; Christophe Béroud 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB 👁 1 views

A detailed analysis of p53 (TP53) mutations involving the 42 CpG dinucleotides was performed to gain greater insight into the mutational mechanism leading to specific selection of these mutations. Although the majority of these CpG dinucleotides have been found to be mutated in cancer cells, the het

Incidence and prognostic significance of

Incidence and prognostic significance of lateral lymph node metastasis in patients with advanced low rectal cancer

✍ M. Ueno; M. Oya; K. Azekura; T. Yamaguchi; T. Muto 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 1 views

## Abstract ## Background Lateral lymph node metastases occur in some patients with low rectal cancer and may cause local recurrence after total mesorectal excision. The aims of this study were to identify risk factors for lateral node metastases in patients with pathological tumour (pT) stage 3 o

TP53 mutations in breast cancer tumors o

TP53 mutations in breast cancer tumors of patients from Rio de Janeiro, Brazil: Association with risk factors and tumor characteristics

✍ Tatiana A. Simão; Fabiana S. Ribeiro; Lídia M. F. Amorim; Rodolpho M. Albano; Ma 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 129 KB 👁 1 views

Somatic mutations in the TP53 gene are the most frequently observed genetic alterations in human malignancies, including breast cancer, which is one of the leading causes of death among women in Brazil. In our study, we determined the frequency and the pattern of TP53 mutations in malignant breast t

Novel TP53 gene mutations in tumors of R

Novel TP53 gene mutations in tumors of Russian patients with breast cancer detected using a new solid phase chemical cleavage of mismatch method and identified by sequencing

✍ A. Lambrinakos; M. Yakubovskaya; J.J. Babon; A.A. Neschastnova; Ya.V. Vishnevska 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 281 KB 👁 2 views

## Communicated by Mark H. Paalman Mutations in the tumor-suppressor p53 gene TP53 are frequent in most human cancers including breast cancer. A new solid phase chemical cleavage of mismatch method (CCM) allowed rapid and efficient screening and analysis of the TP53 gene in DNA samples extracted

Clinical significance of aberrant methyl

Clinical significance of aberrant methylation of prostaglandin E receptor 2 (PTGER2) in nonsmall cell lung cancer : Association with prognosis, PTGER2 expression, and epidermal growth factor receptor mutation

✍ Lei Tian; Makoto Suzuki; Takahiro Nakajima; Rieko Kubo; Yasuo Sekine; Kiyoshi Sh 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB 👁 2 views